Yu, Xin

Synergistic antitumor effects of 9.2.27-PE38KDEL and ABT-737 in primary and metastatic brain tumors. [electronic resource] - PloS one 2019 - e0210608 p. digital

Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, N.I.H., Intramural; Research Support, Non-U.S. Gov't

1932-6203

10.1371/journal.pone.0210608 doi


Animals
Antineoplastic Agents--pharmacology
Antineoplastic Combined Chemotherapy Protocols--pharmacology
Benzothiazoles--pharmacology
Biphenyl Compounds--pharmacology
Brain Neoplasms--drug therapy
Cell Death--drug effects
Cell Line, Tumor
Chondroitin Sulfate Proteoglycans--metabolism
Drug Synergism
Endocytosis--drug effects
Exotoxins--pharmacology
Furin--pharmacology
Humans
Immunotoxins--pharmacology
Isoquinolines--pharmacology
Membrane Proteins--metabolism
Mice, Nude
Models, Biological
Nitrophenols--pharmacology
Piperazines--pharmacology
Proto-Oncogene Proteins c-bcl-2--metabolism
Pyrimidines--pharmacology
Signal Transduction--drug effects
Sulfonamides--pharmacology
Survival Analysis
Thiophenes--pharmacology
Time Factors
Xenograft Model Antitumor Assays